Center-Authored Papers

Filters: Author is Veenstra, David L  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
Bennette CS, Ramsey SD, McDermott CL, Carlson JJ, Basu A, Veenstra DL.  2016.  Predicting Low Accrual in the National Cancer Institute's Cooperative Group Clinical Trials.. Journal of the National Cancer Institute. 108(2) Abstract
Bennette CS, Gallego CJ, Burke W, Jarvik GP, Veenstra DL.  2014.  The cost-effectiveness of returning incidental findings from next-generation genomic sequencing.. Genetics in medicine : official journal of the American College of Medical Genetics. Abstract
Bennette CS, Veenstra DL, Basu A, Baker LH, Ramsey SD, Carlson JJ.  2016.  Development and Evaluation of an Approach to Using Value of Information Analyses for Real-Time Prioritization Decisions Within SWOG, a Large Cancer Clinical Trials Cooperative Group.. Medical decision making : an international journal of the Society for Medical Decision Making. Abstract
Bennette CS, Burke W, Jarvik GP, Veenstra DL.  2015.  Response to phillips et Al.. Genetics in medicine : official journal of the American College of Medical Genetics. 17(4):315.
Bennette CS, Trinidad SB, Fullerton SM, Patrick D, Amendola L, Burke W, Hisama FM, Jarvik GP, Regier DA, Veenstra DL.  2013.  Return of incidental findings in genomic medicine: measuring what patients value-development of an instrument to measure preferences for information from next-generation testing (IMPRINT).. Genetics in medicine : official journal of the American College of Medical Genetics. Abstract
C
Canestaro WJ, Pritchard DE, Garrison LP, Dubois R, Veenstra DL.  2015.  Improving the Efficiency and Quality of the Value Assessment Process for Companion Diagnostic Tests: The Companion test Assessment Tool (CAT).. Journal of managed care & specialty pharmacy. 21(8):700-12. Abstract
Carlson JJ, Reyes C, Oestreicher N, Lubeck D, Ramsey SD, Veenstra DL.  2008.  Comparative clinical and economic outcomes of treatments for refractory non-small cell lung cancer (NSCLC).. Lung cancer (Amsterdam, Netherlands). 61(3):405-15. Abstract
Carlson JJ, Veenstra DL, Ramsey SD.  2008.  Pharmacoeconomic evaluations in the treatment of non-small cell lung cancer.. Drugs. 68(8):1105-13. Abstract
Carlson JJ, Thariani R, Roth J, Gralow J, Henry LN, Esmail L, Deverka P, Ramsey SD, Baker L, Veenstra DL.  2013.  Value-of-Information Analysis within a Stakeholder-Driven Research Prioritization Process in a US Setting: An Application in Cancer Genomics.. Medical decision making : an international journal of the Society for Medical Decision Making. 33(4):463-71. Abstract
Carlson JJ, Garrison LP, Ramsey SD, Veenstra DL.  2009.  The potential clinical and economic outcomes of pharmacogenomic approaches to EGFR-tyrosine kinase inhibitor therapy in non-small-cell lung cancer.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 12(1):20-7. Abstract
Cheng MM, Ramsey SD, Devine EB, Garrison LP, Bresnahan BW, Veenstra DL.  2012.  Systematic review of comparative effectiveness data for oncology orphan drugs.. The American journal of managed care. 18(1):47-62. Abstract
D
Dale CR, Madtes DK, Fan VS, Gorden JA, Veenstra DL.  2012.  Navigational Bronchoscopy With Biopsy Versus Computed Tomography-guided Biopsy for the Diagnosis of a Solitary Pulmonary Nodule: A Cost-Consequences Analysis.. Journal of bronchology & interventional pulmonology. 19(4):294-303. Abstract
Deverka PA, Lavallee DC, Desai PJ, Armstrong J, Gorman M, Hole-Curry L, O'Leary J, Ruffner B, Watkins J, Veenstra DL et al..  2012.  Facilitating comparative effectiveness research in cancer genomics: evaluating stakeholder perceptions of the engagement process.. Journal of comparative effectiveness research. 1(4):359-370. Abstract
E
Esmail LC, Roth J, Rangarao S, Carlson JJ, Thariani R, Ramsey SD, Veenstra DL, Deverka P.  2013.  Getting our priorities straight: a novel framework for stakeholder-informed prioritization of cancer genomics research.. Genetics in medicine : official journal of the American College of Medical Genetics. 15(2):115-122. Abstract
G
Gallego CJ, Shirts BH, Bennette CS, Guzauskas G, Amendola LM, Horike-Pyne M, Hisama FM, Pritchard CC, Grady WM, Burke W et al..  2015.  Next-Generation Sequencing Panels for the Diagnosis of Colorectal Cancer and Polyposis Syndromes: A Cost-Effectiveness Analysis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Abstract
Gallego CJ, Bennette CS, Heagerty P, Comstock B, Horike-Pyne M, Hisama F, Amendola LM, Bennett RL, Dorschner MO, Tarczy-Hornoch P et al..  2014.  Comparative effectiveness of next generation genomic sequencing for disease diagnosis: Design of a randomized controlled trial in patients with colorectal cancer/polyposis syndromes.. Contemporary clinical trials. Abstract
Gaskill CE, Kling CE, Varghese TK, Veenstra DL, Thirlby RC, Flum DR, Alfonso-Cristancho R.  2017.  Financial benefit of a smoking cessation program prior to elective colorectal surgery.. The Journal of surgical research. 215:183-189. Abstract
Goddard KAB, Knaus WA, Whitlock E, Lyman GH, Feigelson HS, Schully SD, Ramsey S, Tunis S, Freedman AN, Khoury MJ et al..  2012.  Building the evidence base for decision making in cancer genomic medicine using comparative effectiveness research.. Genetics in medicine : official journal of the American College of Medical Genetics. Abstract
Green RC, Goddard KAB, Jarvik GP, Amendola LM, Appelbaum PS, Berg JS, Bernhardt BA, Biesecker LG, Biswas S, Blout CL et al..  2016.  Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine.. American journal of human genetics. 98(6):1051-1066. Abstract
H
Hart R, Veenstra DL, Boudreau DM, Roth JA.  2016.  The Impact of Body Mass Index and Genetics on Warfarin Major Bleeding Outcomes in a Community Setting.. The American journal of medicine. Abstract
R
Ramsey SD, Henry LN, Gralow JR, Mirick DK, Barlow W, Etzioni R, Mummy D, Thariani R, Veenstra DL.  2015.  Tumor marker usage and medical care costs among older early-stage breast cancer survivors.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 33(2):149-55. Abstract
Roth JA, Garrison LP, Burke W, Ramsey SD, Carlson R, Veenstra DL.  2011.  Stakeholder perspectives on a risk-benefit framework for genetic testing.. Public health genomics. 14(2):59-67. Abstract
Roth JA, Bradley K, Thummel KE, Veenstra DL, Boudreau D.  2015.  Alcohol misuse, genetics, and major bleeding among warfarin therapy patients in a community setting.. Pharmacoepidemiology and drug safety. 24(6):619-627. Abstract
S
Sullivan SD, Yeung K, Vogeler C, Ramsey SD, Wong E, Murphy CO, Danielson D, Veenstra DL, Garrison LP, Burke W et al..  2015.  Design, implementation, and first-year outcomes of a value-based drug formulary.. Journal of managed care & specialty pharmacy. 21(4):269-75. Abstract
T
Thariani R, Veenstra DL, Carlson JJ, Garrison LP, Ramsey S.  2012.  Paying for personalized care: cancer biomarkers and comparative effectiveness.. Molecular oncology. 6(2):260-6. Abstract